Press Room

Event

2024 AIChE Annual meeting

Start

Sunday, October 27, 2024 - 08:00

End

Thursday, October 31, 2024 - 18:00

Location: San Diego, United States

Meet Hovione team at the 2024 AIChE Annual Meeting and find their exciting presentations and Hovione’s latest research and innovations. The AIChE Annual Meeting is an educational forum covering a wide range of topics relevant to cutting-edge research, new technologies, and emerging growth areas in chemical engineering. We look forward to meeting academic and industry experts and exchanging knowledge.

Date: October 28, 2024

Oral Presentation

Title: High Pressure Reaction Kinetic Modeling: Leveraging Single Data-Rich Experiment

Presenting Author: Ines Rocha – Scientist, Process Scale-up

9:45 AM - 10:06 AM

Room 29C (Upper Level, SDCC)

Oral Presentation

Title: Integrating Amorphous Solid Dispersions (ASDs) in a PBPK Software

Presenting Author: Pedro Monteiro – Senior Scientist, Formulation Development

10:06 AM - 10:27 AM

Room 29D (Upper Level, SDCC)

Oral Presentation

Title: Comprehensive Powder Flow Characterization with Reduced Testing

Presenting Author: Maria Paisana – Senior Scientist, Lead Analytical Scientists

12:50 PM - 1:10 PM

Sapphire 400B (4, Hilton Bayfront)

Oral Presentation

Title: Bayesian Optimization Applied to Chemical Reaction Optimization: Human-in-Loop and Cdmo Perspective

Presenting Author: Ines Rocha – Scientist, Process Scale-up

12:50 PM - 1:10 PM

Room 29D (Upper Level, SDCC)

Date: October 29, 2024

Oral Presentation

Title: Tswg Development and Scale up from Laboratory Benchtop Experiments

Presenting Author: Ricardo Sousa – Senior Scientist, Formulation Development

8:30 AM - 8:45 AM

Cobalt 520 (5, Hilton Bayfront)

Oral Presentation

Title: Scaling Continuous Powder Blenders: The Length-Scale Problem

Presenting Author: Scientific Fellow, Continuous Tableting

1:06 PM - 1:24 PM

Sapphire Ballroom M (4, Hilton Bayfront)

Date: October 30, 2024

Oral Presentation

Title: Path to Commercial Reality of Continuous Manufacturing - a Cdmo Perspective

Presenting Author: Jose Luis Santos – R&D Director, Technology Intensification

9:45 AM - 10:06 AM

Room 29C (Upper Level, SDCC)

Oral Presentation

Title: Methodology for Rapid Development of a Continuous Loss-in-Weight Feeding Process

Presenting Author: Ana Martins – PhD Student

1:12 PM - 1:33 PM

Room 29C (Upper Level, SDCC)

Poster Presentation

Title: Direct Scale-up of a Dry Granulation Process Using a Material Lean Approach at Lab-Scale

Presenting Author: Ricardo Sousa – Senior Scientist, Formulation Development

10:06 AM - 10:27 AM

Exhibit Hall GH (Ground Level, SDCC)

Date: October 31, 2024

Oral Presentation

Title: Formulating Amorphous Solid Dispersions into Oral Dosage Forms: A Fast to Market Integrated Approach

Presenting Author: Patricia Cruz

12:51 PM - 1:12 PM

Room 29C (Upper Level, SDCC)

Oral Presentation

Title: Leveraging COSMO-RS for Chemical Development and Scale-up in the Pharmaceutical Industry

Presenting Author: Ines Rocha – Scientist, Process Scale-up

3:30 PM - 3:48 PM

Room 30E (Upper Level, SDCC)

Let’s discuss your project together.

Find more about AIChE Annual Meeting

You might be interested in:

Drug Substance at Hovione

Your partner in custom development and manufacturing of APIs.

The Leader in Spray Drying

Know how to overcome your solubility issues with the best scale-up science.

The Future is Continuous

Meet our experts and find out if Continuous Tableting is right for your product.

Industrialization of Innovative Platforms

Learn more about our Large-scale GMP-compliant platforms that support your project from development to commercialization.

Also in the Press Room

See All

Hovione is bringing momentum to the intranasal field after announcing that its lead single-use nasal dry powder device, developed in collaboration with Industrial Design Consultancy Ltd (IDC), is now available for commercial partnerships. The milestone marks the transition from prototype to a fully integrated intranasal drug delivery platform that spans Hovione’s end-to-end partnership capabilities–from API synthesis through advanced formulation and particle engineering to drug product manufacturing, including device supply and advanced analytical tools for nasal performance characterization. The platform’s single-use device is designed to be manufacturable at scale and to leverage existing advanced particle engineering and drug product manufacturing capabilities, a practical advantage that can shorten timelines to clinic and commercialization while reducing development risk and cost. The device’s patented mechanism supports targeted nasal deposition, including access to the upper olfactory region. This enables rapid systemic absorption and potential nose-to-brain delivery pathways that are increasingly important for CNS and emergency-use indications. Beyond the single-use format, Hovione and IDC are advancing a multi-dose variant to broaden applicability across dosing regimens and therapeutic areas. The collaboration is backed by an intellectual property portfolio and initial patent grants, positioning the platform as a turnkey option for pharma partners seeking a single integrated supplier for both drug substance and device. This development arrives as intranasal delivery gains traction for systemic, CNS and rapid-onset therapies. This is precisely the focus of the upcoming 4th Nasal Formulation & Delivery Summit, for which Hovione is a key sponsor. The annual summit unites formulation, delivery and product development leaders to tackle drug-device compatibility, translational preclinical models, and strategies for scalable, regulatory-ready intranasal programs. Hovione’s recent progress will be highly relevant to attendees looking to de-risk nose-to-brain and systemic intranasal programs. Read the full article at News-Medical.net

Press Clipping

News Medical Life Sciences, 1 June 2026

Hovione advances intranasal drug delivery with commercial-ready dry powder platform ahead of 4th Nasal Formulation & Delivery Summit

Jun 01, 2026

Every year, the largest bank in Portugal, Caixa Geral de Depósitos recognizes some of Portugal’s brightest young minds through the Caixa +Mundo Awards, providing nearly €800,000 in scholarships to students as they pursue higher education. In this year´s edition, Caixa named the award bestowed upon students pursuing science for Diane Villax. This prestigious honor places Diane Villax among the award’s namesakes – a distinguished group of prominent personalities who have made notable contributions to Portugal´s socio-economic, cultural, political and scientific development over the last 50 years, such as António Ramalho Eanes, Mário Soares, José Saramago, Sophia de Mello Breyner, Leonor Beleza, Elvira Fortunato, Rui Nabeiro, Américo Amorim, and José Manuel de Mello. Diane Villax will also honor the seven scientific award winners by personally meeting with each of them, and following their journeys as future innovators and leaders. But this honor is about far more than one individual. It is a celebration of an entire organization and the people behind it. For 67 years, generations of dedicated teams have worked together with passion, purpose, and excellence to manufacture life-saving medicines and advance science that has a real impact on people. This recognition belongs to all of us.

News

Prestigious Caixa +Mundo Award named in honor of Diane Villax

May 14, 2026

CDMO Hovione and Industrial Design Consultancy (IDC) have announced that their new single-use capsule-based nasal delivery device is now available exclusively as part of an integrated platform that includes Hovione’s intranasal drug development and manufacturing services. The companies partnered in 2023 with plans for development of two capsule-based devices for intranasal delivery: the single-use device and a multidose device. Read the full article at OINDPnews.com

Press Clipping

OINDP - Orally inhaled and nasal drug products news, May 11, 2026